Dr. Hyo Soo Kim and Dr. C. Michael Gibson Discuss: HOST-EXAM – Long Term Follow-Up of Aspirin vs. Clopidogrel Monotherapy in the Chronic Maintenance Period After Percutaneous Coronary Intervention: The Host-Exam Extended Study November 7, 2022 Disclosures: TBD
Dr. Erlend Berg and Dr. C. Michael Gibson Discuss: After Eighty Study – Long-Term Outcomes of an Invasive versus Conservative Strategy in Stabilised Patients Aged 80 Years or Older With Non-ST-Elevation Acute Coronary Syndrome, After Eighty Study: A Randomised Controlled Trial November 7, 2022 Disclosures: TBD
Dr. Judith Hochman and Dr. C. Michael Gibson Discuss: ISCHEMIA-EXTENDed – Follow-Up Interim Report November 6, 2022 Disclosures: TBD
Dr. Pamela Douglas and Dr. C. Michael Gibson Discuss: PRECISE – Comparison of a Precision Care Strategy with Usual Testing to Guide Management of Stable Patients With Suspected Coronary Artery Disease: The Precise Randomized Trial November 6, 2022 Disclosures: TBD
Dr. Michelle O’Donoghue and Dr. C. Michael Gibson Discuss: OCEAN(a)-DOSE – Reduction of Lipoprotein(a) With Small Interfering RNA: The Results of the Ocean(a)-DOSE Trial November 6, 2022 Disclosures: TBD
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: BRIGHT-4 – Bivalirudin With a Post-PCI High-Dose Infusion versus Heparin Monotherapy During Primary PCI in STEMI: The Randomized Bright-4 Trial November 6, 2022 Disclosures: TBD
Dr. Hiroyuki Daida and Dr. C. Michael Gibson Discuss: RESPECT-EPA – Randomized Trial for Evaluating Secondary Prevention Efficacy of Combination Therapy – Statin and Eicosapentaenoic Acid November 6, 2022 Disclosures: TBD
Dr. Mark Huffman and Dr. Yazan Daaboul Discuss: QUARTET USA – Efficacy and Safety of a Quadruple Ultra-Low-Dose Treatment for Hypertension (QUARTET USA): A Randomized Controlled Trial November 6, 2022 Disclosures: TBD
Dr. Paul Kalra and Dr. C. Michael Gibson Discuss: IRONMAN – Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure with Reduced Ejection Fraction November 6, 2022 Disclosures: TBD
Dr. Petr Ostadal and Dr. C. Michael Gibson Discuss: ECMO-CS – Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: Primary Results from the Multicenter, Randomized ECMO-CS Trial November 6, 2022 Disclosures: TBD
